Johan Auwerx
Director/Board Member at NOVMETAPHARMA CO., LTD.
Johan Auwerx active positions
Companies | Position | Start | End |
---|---|---|---|
NOVMETAPHARMA CO., LTD. | Director/Board Member | - | - |
Corporate Officer/Principal | - | - | |
Reamol Biomedical Consulting Sàrl LLC | Chief Executive Officer | 2013-03-31 | - |
École Polytechnique Fédérale de Lausanne | Corporate Officer/Principal | 2007-12-31 | - |
Career history of Johan Auwerx
Former positions of Johan Auwerx
Companies | Position | Start | End |
---|---|---|---|
CareX SA
CareX SA Pharmaceuticals: MajorHealth Technology CareX SA is a privately held biopharmaceutical company located in Strasbourg, France, that is committed to the discovery and development of innovative, safe and effective medicines for the treatment of diseases linked to the metabolic syndrome. The company was founded in 2001 and is headquartered in Illkirch-Graffenstaden, France | Founder | 2001-11-01 | - |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Founder | 2013-09-30 | - |
Training of Johan Auwerx
Katholieke Universiteit Leuven | Doctorate Degree |
Statistics
International
Switzerland | 3 |
France | 2 |
Belgium | 2 |
Operational
Founder | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Private companies | 3 |
---|---|
CareX SA
CareX SA Pharmaceuticals: MajorHealth Technology CareX SA is a privately held biopharmaceutical company located in Strasbourg, France, that is committed to the discovery and development of innovative, safe and effective medicines for the treatment of diseases linked to the metabolic syndrome. The company was founded in 2001 and is headquartered in Illkirch-Graffenstaden, France | Health Technology |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Health Technology |
Reamol Biomedical Consulting Sàrl LLC |
- Stock Market
- Insiders
- Johan Auwerx
- Experience